CLINICAL ASPECTS OF THE TOXICITY OF POLYMYXINS A, B, AND E
- 17 January 1953
- journal article
- Published by Elsevier in The Lancet
- Vol. 261 (6751) , 110-112
- https://doi.org/10.1016/s0140-6736(53)90828-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- INFECTIONS WITH PSEUDOMONAS AERUGINOSA TREATED WITH POLYMYXIN BArchives of internal medicine (1960), 1952
- HÆMOPHILUS INFLUENZÆ MENINGITIS TREATED WITH POLYMYXINThe Lancet, 1951
- PSEUDOMONAS PYOCYANEA IN BURNS: ITS ROLE AS A PATHOGEN, AND THE VALUE OF LOCAL POLYMYXIN THERAPYThe Lancet, 1951
- PSEUDOMONAS MENINGITISA.M.A. Archives of Internal Medicine, 1951
- The role of some higher peptides in inflammationThe Journal of Pathology and Bacteriology, 1951
- MENINGITIS DUE TO PSEUDOMONAS AERUGINOSA TREATED WITH POLYMYXIN BThe Lancet Healthy Longevity, 1950
- Crystalline Derivatives of the Polymyxins and the Identification of the Fatty Acid ComponentNature, 1949
- CHEMICAL STUDIES ON POLYMYXIN: COMPARISON WITH “AEROSPORIN”Annals of the New York Academy of Sciences, 1949
- THE CLINICAL USE OF POLYMYXINAnnals of the New York Academy of Sciences, 1949
- TREATMENT OF PERTUSSIS WITH AEROSPORINThe Lancet, 1948